Thrombocytopenia Alloimmune: Clinical Trials

1 trial for Thrombocytopenia Alloimmune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow Thrombocytopenia Alloimmune: new trials by email Literature Review of Thrombocytopenia Alloimmune trials Research Report on Thrombocytopenia Alloimmune

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
anti-CD19 CAR NK cells (KN5501) - Thrombocytopenia Alloimmune
Early Phase 1RecruitingChangzhou No.2 People's Hospital92024-08-302025-04-30

Sponsors

Changzhou No.2 People's Hospital (1)

Countries

China (1)